Mold-Tek Technologies Limited (MOLDTECH)
Outcome of Board Meeting
Q2FY27 results (unaudited):
Standalone:
Revenue 4.7bn +25% y-y (3.7bn)
EBITDA 1.5bn +157% y-y (0.6bn)
EBITDA margin 31.4% (15.8%) +1560 bps y-y
PAT 1.0bn +223% y-y (0.3bn)
Consolidated:
Revenue 6.1bn +51% y-y (4.0bn)
EBITDA 1.5bn +145% y-y (0.6bn)
EBITDA margin 24.0% (14.8%) +920 bps y-y
PAT 0.96bn +197% y-y (0.32bn)
H1FY27 results (unaudited):
Standalone:
Revenue 9.2bn +39% y-y (6.6bn)
EBITDA 3.0bn +265% y-y (0.8bn)
EBITDA margin 32.6% (12.4%) +2200 bps y-y
PAT 2.0bn +440% y-y (0.4bn)
Consolidated:
Revenue 12.0bn +64% y-y (7.4bn)
EBITDA 2.8bn +239% y-y (0.8bn)
EBITDA margin 23.7% (11.4%) +1230 bps y-y
PAT 1.9bn +375% y-y (0.4bn)
Dividend: None declared
Commentary: Company delivered highest-ever quarterly profits driven by strong execution, business diversification and U.S. expansion; expects bright future with growth in civil engineering and new client additions.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 MOLDTECH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add MOLDTECH to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Mold-Tek Technologies Limited
Important.
The summary above is generated automatically from Mold-Tek Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.